Acasă › Melanom › Utah › Salt Lake City
Studii clinice pentru Melanom în Salt Lake City, UT
21 studii pentru Melanom caută participanți în și în jurul orașului Salt Lake City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
În curs de recrutareFaza 2
- Huntsman Cancer Institute, Salt Lake City
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
În curs de recrutareFaza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
În curs de recrutareFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
În curs de recrutareFaza 3
- Intermountain Health, Salt Lake City
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
În curs de recrutareFaza 2
- Primary Children's Hospital, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
În curs de recrutareFaza 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
În curs de recrutareFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- Utah Cancer Specialists, Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Project: Every Child for Younger Patients With Cancer
În curs de recrutareStudiu observațional
- Primary Children's Hospital, Salt Lake City
Rural Adult and Youth Sun Protection Study
În curs de recrutareVoluntari sănătoși bineveniți
- University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
În curs de recrutare
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
În curs de recrutare
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
În curs de recrutareFaza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
În curs de recrutareFaza 3
- Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute - University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
În curs de recrutare
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Studii pentru Melanom în alte orașe
- Houston, TX59 studii
- New York City, NY38 studii
- Los Angeles, CA34 studii
- Nashville, TN33 studii
- Pittsburgh, PA31 studii
- Boston, MA26 studii
- Philadelphia, PA23 studii
- San Francisco, CA22 studii
- Columbus, OH21 studii
- Durham, NC21 studii
- Atlanta, GA21 studii
- St. Louis, MO21 studii
Alte studii în Salt Lake City
- Cancer pulmonar cu celule non-pătrate31 studii
- Cancer (toate tipurile)27 studii
- Cancer de sân27 studii
- Cancer colorectal22 studii
- Cancer pulmonar21 studii
- Mielom multiplu21 studii
- Cancer metastatic20 studii
- Cancer ovarian19 studii
- Obezitate18 studii
- Leucemie mieloasă acută17 studii
- Insuficiență cardiacă17 studii
- Cancer de prostată15 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.